Neonc Technologies Holdings, Inc. (NTHI)
NASDAQ·Healthcare·Biotechnology
$5.11
-1.35%
Mkt Cap $188.76M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$16.00
Range $13.00 – $20.00
Implied Upside
+213.1%
Consensus $16.00 vs current $5.11